Saccomano Nicholas A Insider Trades & Stock Holdings

President and CEO · OnKure Therapeutics, Inc. · Latest filing Sep 21, 2026

Saccomano Nicholas A, President and CEO at OnKure Therapeutics, Inc. has 1 Form 4 trade on file since Sep 21, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($258.76), net -$258.76. Latest filing: disposed of 87 shares of $OKUR on Sep 21, 2026 at $2.97.

Trades on file

1

Open-market bought

$0

Open-market sold

$258.76

Net open-market

-$258.76

Latest filing

Sep 21, 2026

All insider trades by Saccomano Nicholas A

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 21, 2026	$OKUR	Sell (Open-market sale)	87	$2.97	$258.76						President and CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Saccomano Nicholas A traded

• $OKUR

Frequently asked questions

Has Saccomano Nicholas A been buying or selling stock?

Saccomano Nicholas A has 0 open-market purchases and 1 open-market sale on file, net -$258.76. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Saccomano Nicholas A's latest insider trade?

disposed of 87 shares of $OKUR on Sep 21, 2026 at $2.97.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.